, Volume 32, Supplement 4, pp 177–205 | Cite as

Non-Narcotic Analgesics

Problems of Overdosage
  • T. J. Meredith
  • J. A. Vale
  • Y. A. Vale


The first cases of fulminant hepatic failure due to paracetamol poisoning were reported in 1966, and in the United Kingdom this condition is now responsible for more cases of acute hepatic failure than any other cause. Adults account for the majority of serious and fatal cases of paracetamol poisoning and it is extremely rare for young children to ingest sufficient paracetamol to cause more than minimal liver damage. A single measurement of the plasma paracetamol concentration is an accurate predictor of liver damage provided that it is taken not earlier than 4 hours after ingestion of the overdose. Peak disturbance of liver function occurs 2 to 4 days after the overdose, often accompanied by mild jaundice, after which recovery is usually rapid and complete. In a few patients, fulminant hepatic failure, manifested by increasing jaundice and encephalopathy, may develop by the third to fifth day. Acute renal failure may complicate paracetamol poisoning, often in the context of severe liver damage. Renal failure, which is often non-oliguric, typically becomes apparent 24 to 72 hours after overdosage.

The treatment of paracetamol intoxication should include gastric lavage, which has been shown to be of value for up to 6 hours after ingestion of a paracetamol overdose. Further general treatment may include parenteral fluid replacement and a prophylactic infusion of dextrose (5–10%) in patients at risk of hepatic failure. Specific protective agents in those patients at risk of paracetamol-induced liver damage include N-acetylcysteine and methionine which are most effective if given within 8 to 10 hours of ingestion of the overdose. Hepatic and renal failure should be managed conventionally.

In recent years in the United Kingdom there has been a gradual decline in the number of hospital admissions and the number of deaths from aspirin poisoning. Salicylates in overdose directly stimulate the respiratory centre and so cause a respiratory alkalosis. Metabolic acidosis occurs in severe poisoning because of impairment of the oxidative metabolism of energy substrates. At very high salicylate concentrations respiratory depression may occur, possibly associated with neuroglycopenia, adding respiratory acidosis to the worsening metabolic acidosis. In addition to a mixed acid-base disturbance, hypokalaemia and hypoglycaemia may be present. Nausea and vomiting increase the fluid deficit. If dehydration is sufficiently severe, decreasing cardiac output may hasten development of lactic acidosis and acute renal failure. Young children quickly develop a metabolic acidosis following the ingestion of aspirin in overdose but, by the age of 12 years, the usual adult picture of a mixed respiratory alkalosis and metabolic acidosis is seen.

The treatment of salicylate poisoning is directed towards prevention of absorption, correction of acid-base, fluid and electrolyte disturbance and measures to increase the elimination of salicylate in those who are moderately or severely poisoned. It is now recognised that if alkaline diuresis is employed urine pH is of far greater importance than the volume of urine excreted.

Despite the widespread therapeutic use of non-steroidal anti-inflammatory drugs (NSAIDs) the current number of reported cases of poisoning is small. Initially, propionic acid derivatives were thought to have a low toxicity in overdose but, in addition to anticipated gastrointestinal symptoms (nausea, vomiting, abdominal pain, haematemesis), headache, tinnitus, hyperventilation, sinus tachycardia, hypoprothrombinaemia, haematuria, proteinuria and acute renal failure have been described. In addition, drowsiness, coma, nystagmus, diplopia, hypothermia, hypotension, respiratory depression and cardiac arrest have been reported in severe cases of poisoning. The oxicam derivative, piroxicam, is potentially very toxic in overdose.

Oxyphenbutazone and phenylbutazone are very toxic in overdose but indomethacin appears to be much less toxic. An overdose of mefenamic acid may result in nausea, vomiting, muscle twitching, convulsions and coma.

Management of NSAID overdose is essentially supportive and symptomatic. If a substantial overdose of an NSAID has been ingested (e.g. more than 10 therapeutic doses in an adult; 5 doses in a child), and if the patient presents not more than 4 hours after a substantial overdose, an attempt should be made to reduce absorption of toxic material by undertaking gastric lavage. Alternatively, if the patient presents within 1–2 hours of overdose, activated charcoal 50 to 100g may be administered. Thereafter supportive measures may be needed and dialysis will be required if renal failure becomes established. As most NSAIDs are highly protein bound and extensively metabolised, forced, diuresis, dialysis and haemoperfusion are unlikely to enhance elimination significantly.


Paracetamol Salicylate British Medical Journal Activate Charcoal Cysteamine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahlfors, C.E.; Shwer, M.L and Ford, K.B.: Bilirubin — albumin binding in neonatal salicylate intoxication. Developmental Pharmacology and Therapeutics 4: 47–60 (1982).PubMedGoogle Scholar
  2. Alam, S.N.; Roberts, R.J. and Fischer, L.J.: Age-related differences in salicylamide and acetaminophen conjugation in man. Journal of Pediatrics 90: 130–135 (1977).PubMedGoogle Scholar
  3. Anderson, R.J.; Potts, D.E.; Gabow, P.A.; Rumack, B.H. and Schrier, R.W.: Unrecognised adult salicylate intoxication. Annals of Internal Medicine 85: 745–748 (1976).PubMedGoogle Scholar
  4. Anon.: Butazolidin fatality. Pharmaceutical Journal 194: 604 (1965).Google Scholar
  5. Anon.: Death after N-acetylcysteine. Lancet 1: 1421 (1984).Google Scholar
  6. Appleby, D.H.: Fenoprofen (Nalfon) overdose. Drug Intelligence and Clinical Pharmacy 15: 129–130 (1981).PubMedGoogle Scholar
  7. Arena, J.M.; Rourke, M.H. and Sibrack C.D.: Acetaminophen: Report of an unusual poisoning. Pediatrics 61: 68–72 (1978).PubMedGoogle Scholar
  8. Balali-Mood, M. and Prescott, I.F.: Failure of alkaline diuresis to enhance diflunisal elimination. British Journal of Clinical Pharmacology 10: 163–165 (1980).PubMedGoogle Scholar
  9. Balali-Mood, M.; Critchley, J.A.J.H, Proudfoot, A.T. and Prescott, L.F.: Mefenamic acid overdosage. Lancet 1: 1354–1356 (1981).PubMedGoogle Scholar
  10. Barry, W.S.; Meinzinger, M.M. and Howse, C.R.: Ibuprofen overdose and exposure in utero: Results from a post-marketing voluntary reporting system. American Journal of Medicine (Symposium) July 13th, 35–39 (1984).Google Scholar
  11. Bateman, D.N.; Woodhouse, K.W. and Rawlins, M.D.: Adverse reactions to N-acetylcysteine. Human Toxicology 3: 393–398 (1984).PubMedGoogle Scholar
  12. Bates, T.: Phenylbutazone. Pediatrics 17: 967–968 (1956).PubMedGoogle Scholar
  13. Benson, G.D.: Hepatotoxicity following the therapeutic use of antipyretic analgesics. American Journal of Medicine 75 (Suppl.): 85–93 (1983).PubMedGoogle Scholar
  14. Berg, K.J.: Acute acetylsalicylic acid poisoning: Treatment with forced alkaline diuresis and diuretics. European Journal of Clinical Pharmacology 12: 111–116 (1977).PubMedGoogle Scholar
  15. Beringer, T.R.O.: Salicylate intoxication in the elderly due to benorylate. British Medical Journal 288: 1344–1355 (1984).PubMedGoogle Scholar
  16. Berlinger, W.G.; Spector, R.; Flanigan, M.J.; Johnson, G.F. and Groh, M.R.: Hemoperfusion for phenylbutazone poisoning. Annals of Internal Medicine 96: 334–335 (1982).PubMedGoogle Scholar
  17. Black, R.A. and Bensinger, R.E.: Bilateral subconjunctival haemorrhage after acetylsalicylic acid overdose. Annals of Ophthalmology 14: 1024–1025 (1982).PubMedGoogle Scholar
  18. Boldy, D.A.R. and Vale, J.A.: Treatment of salicylate poisoning with repeated oral charcoal. British Medical Journal 292: 136 (1986).PubMedGoogle Scholar
  19. Boyd, E.H. and Bereczky, G.M.: Liver necrosis from paracetamol. British Journal of Pharmacology 26: 606–614 (1966).Google Scholar
  20. Boyd, J.A. and Eling, T.E.: Prostaglandin endoperoxide synthetase-dependent cooxidation of acetaminophen to intermediates which covalently bind in vitro to rabbit renal medullary microsomes. Journal of Pharmacology and Experimental Therapeutics 219: 659–664 (1981).PubMedGoogle Scholar
  21. Brancato, D.J. and Nelson, R.C.: Poisoning mortality in the United States 1980. Veterinary and Human Toxicology 26: 273–275 (1984).Google Scholar
  22. Budd, R.D.: Gas Chromatographic determination of butazolidin (phenylbutazone) I in biological fluids. Journal of Chromatography 243: 368–371 (1982).PubMedGoogle Scholar
  23. Bury, R.W.; Mashford, M.L.; Glaun, B.P. and Saaroni, G.: Acute phenylbutazone poisoning in a child. Medical Journal of Australia 1: 478–479 (1983).PubMedGoogle Scholar
  24. Caldwell, J.; Smith, R.L. and Davies, S.A.: Drug metabolism in a case of progeria. Gerontology 24: 373–380 (1978).PubMedGoogle Scholar
  25. Canalese, J.; Gimson, A.E.S.; Davis, M. and Williams, R.: Factors contributing to mortality in paracetamol-induced hepatic failure. British Medical Journal 282: 199–201 (1981).PubMedGoogle Scholar
  26. Clark, R.; Borirakchanyavat, V.; Davidson, A.R.; Thompson, R.P.H.; Widdop, B.; Goulding, R. and Williams, R.: Hepatic damage and death from overdose of paracetamol. Lancet 1: 66–70 (1973a).PubMedGoogle Scholar
  27. Clark, R.; Borirakchanyavat, V.; Gazzard, B.G.; Rake, M.O.; Shilkin, K.B.; Flute, P.T. and Williams, R.: Disordered hemostasis in liver damage from paracetamol overdose. Gastroenterology 65: 788–795 (1973b).PubMedGoogle Scholar
  28. Clarke, J.H. and Wilson, W.G.: A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clinical Pediatrics 20: 53–54 (1981).Google Scholar
  29. Cobden, I.; Record, C.O.; Ward, M.K. and Kerr, D.N.S.: Paracetamol-induced acute renal failure in the absence of fulminant liver damage. British Medical Journal 284: 21–22 (1982).PubMedGoogle Scholar
  30. Cohen, C.: Salicylate intoxication in the elderly due to benorylate. British Medical Journal 288: 1617 (1984).Google Scholar
  31. Cotton, E.K. and Fahlberg, V.l.: Hypoglycaemia with salicylate poisoning: A report of two cases. American Journal of Diseases of Children 108: 171–173 (1964).PubMedGoogle Scholar
  32. Court, H. and Volans, G.N.: Poisoning after overdose with non-steroidal anti-inflammatory drugs. Adverse Drug Reactions and Acute Poisoning Reviews 3: 1–21 (1984).PubMedGoogle Scholar
  33. Court, H.; Streete, P. and Volans, G.N.: Acute poisoning with ibuprofen. Human Toxicology 2: 381–384 (1983).PubMedGoogle Scholar
  34. Crome, P.; Vale, J.A.; Volans, G.N.; Widdop, B. and Goulding, R.: Oral methionine in the treatment of severe paracetamol (acetaminophen) overdose. Lancet 2: 829–830 (1976).PubMedGoogle Scholar
  35. Cumming, G.; Dukes, D.C. and Widdowson, G.: Alkaline diuresis in treatment of aspirin poisoning. British Medical Journal 2: 1033–1036 (1964).PubMedGoogle Scholar
  36. Curry, R.W.; Robinson, J.D. and Sughrue, M.J.: Acute renal failure after acetaminophen poisoning. Journal of the American Medical Association 247: 1012–1014 (1982).PubMedGoogle Scholar
  37. Davidson, A.R.; Rojas-Bueno, A.; Thompson, R.P.H. and Williams, R.: Early unconjugated hyperbilirubinaemia after paracetamol overdosage. Scandinavian Journal of Gastroenterology 11: 623–628 (1976).PubMedGoogle Scholar
  38. Davidson, D.G.D. and Eastham, W.N.: Acute liver necrosis following overdose of paracetamol. British Medical Journal 2: 497–499 (1966).PubMedGoogle Scholar
  39. Davies, M.G.; Vella Briffa, D. and Greaves, M.W.: Systemic toxicity from topically applied salicylic acid. British Medical Journal 1: 661 (1979).PubMedGoogle Scholar
  40. Davis, M.; Ideo, G.; Harrison, N.G. and Williams, R.: Early inhibition of hepatic bilirubin conjugation after paracetamol (acetaminophen) administration in the rat. Digestion 13: 42–48 (1975).PubMedGoogle Scholar
  41. Demole, V.: Mesure de l’effet sédatil de la Novaminesulphone. Helvetica Physiologica Pharmacologica Acta 16: C10–C12 (1958).Google Scholar
  42. Devalia, J.L. and McLean, A.E.M.: Covalent binding and the mechanism of paracetamol toxicity. Biochemical Pharmacology 32: 2602–2603 (1983).PubMedGoogle Scholar
  43. Devalia, J.L.; Ogilve, R.C. and McLean, A.E.M.: Dissociation of cell death from covalent binding of paracetamol by flavones in a hepatocyte system. Biochemical Pharmacology 31: 3745–3749 (1982).PubMedGoogle Scholar
  44. Dixon, M.F.: Paracetamol hepatotoxicity. Lancet 1: 35 (1976).Google Scholar
  45. Dixon, M.F.; Nimmo, J. and Prescott, L.F.: Experimental paracetamol-induced hepatic necrosis: A histopathological study. Journal of Pathology 103: 225–229 (1971).PubMedGoogle Scholar
  46. Done, A.K. Aspirin overdosage: Incidence, diagnosis, and management. Pediatrics 62 (Suppl.): 890–897 (1978).PubMedGoogle Scholar
  47. Dordoni, B.; Willson, R.A.; Thompson, R.P.H. and Williams, R.: Reduction of absorption of paracetamol by activated charcoal and cholestyramine: A possible therapeutic approach. British Medical Journal 3: 86–87 (1973).PubMedGoogle Scholar
  48. Douglas, A.P.; Hamlyn, A.N. and James, O.: Controlled trial of cysteamine in treatment of acute paracetamol (acetaminophen) poisoning. Lancet 1: 111–115 (1976).PubMedGoogle Scholar
  49. Dukes, D.C.; Blainey, J.D.; Cumming, G. and Widdowson, G.: The treatment of severe aspirin poisoning. Lancet 1: 329–331 (1963).Google Scholar
  50. El-Bahie, N., Allen, E.M., Williams, J., Routledge, PA. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. British Journal of Clinical Pharmacology 19: 836–838 (1985).PubMedGoogle Scholar
  51. Emby, D.J. and Fraser, B.N.: Hepatotoxicity of paracetamol enhanced by ingestion of alcohol. South African Medical Journal 51: 208–209 (1977).PubMedGoogle Scholar
  52. Farid, N.R.; Glynn, J.P. and Kerr, D.N.S.: Haemodialysis in paracetamol self-poisoning. Lancet 2: 396–398 (1972).PubMedGoogle Scholar
  53. Farrand, R.J.; Green, J.H. and Haworth, C.: Enteric-coated aspirin overdose and gastric perforation. British Medical Journal 3: 85–86 (1975).Google Scholar
  54. Ferguson, R.K. and Boutros, A.R.: Death following self-poisoning with aspirin. Journal of the American Medical Association 213: 1186–1187 (1970).PubMedGoogle Scholar
  55. Forrest, J.A.H.; Roscoe, P.; Prescott, L.F. and Stevenson, I.H.: Abnormal drug metabolism after barbiturate and paracetamol overdose. British Medical Journal 4: 499–502 (1974).PubMedGoogle Scholar
  56. Fredell, E.W. and Strand, L.J.: Naproxen overdose. Journal of the American Medical Association 238: 938 (1977).PubMedGoogle Scholar
  57. Freestone, S. and Critchley, J.A.J.H.: Self poisoning with sutoprofen. British Medical Journal 289: 470 (1984).Google Scholar
  58. Gabow, P.A.; Anderson, R.J.; Potts, D.E. and Schrier, R.W.: Acid-base disturbances in the salicylate-intoxicated adult. Archives of Internal Medicine 138: 1481–1484 (1978).PubMedGoogle Scholar
  59. Gazzard, B.G.; Clark, R.; Borirakchanyavat, V. and Williams, R.: A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis. Gut 15: 89–93 (1974a).PubMedGoogle Scholar
  60. Gazzard, B.G.; Willson, R.A.; Weston, M.J.; Thompson, R.P.H. and Williams, R.: Charcoal haemoperfusion for paracetamol overdose. British Journal of Clinical Pharmacology 1: 271–275 (1974b).PubMedGoogle Scholar
  61. Gazzard, B.G.; Henderson, J.M. and Williams, R.: Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh plasma therapy. Gut 16: 617–620 (1975).PubMedGoogle Scholar
  62. Gazzard, B.G.; Hughes, R.D.; Widdop, B.; Goulding, R.; Davis, M. and Williams, R.: Early prediction of the outcome of a paracetamol overdose based on an analysis of 163 patients. Postgraduate Medical Journal 53: 243–247 (1977).PubMedGoogle Scholar
  63. Gerber, J.G.; MacDonald, J.S.; Harbison, R.D.; Villeneuve, J.-P.; Wood, A.J.Y. and Nies, A.S.: Effect of N-acetylcysteine on hepatic covalent binding of paracetamol (acetaminophen). Lancet 1: 657–658 (1977).PubMedGoogle Scholar
  64. Goldfinger, R.; Ahmed, K.S.; Pitchumoni, C.S. and Weseley, S.A.: Concomitant alcohol and drug abuse enhancing acetaminophen toxicity. American Journal of Gastroenterology 70: 385–388 (1978).PubMedGoogle Scholar
  65. Gross, G.E.: Granulocytosis and a sulindac overdose. Annals of Internal Medicine 96: 793–794 (1982).PubMedGoogle Scholar
  66. Hamlyn, A.N.: Paracetamol poisoning. British Medical Journal 2: 1089 (1978).PubMedGoogle Scholar
  67. Hamlyn A.N.; Douglas, A.P.; James, O.F.W.; Lesna, M. and Watson, A.J.: Liver function and structure in survivors of acetaminophen poisoning. A follow-up study of serum bile acids and liver histology. Digestive Diseases 22: 605–610 (1977).Google Scholar
  68. Hamlyn, A.N.; Douglas, A.P. and James, O.: The spectrum of paracetamol (acetaminophen) overdose: Clinical and epidemiological studies. Postgraduate Medical Journal 54: 400–404 (1978).PubMedGoogle Scholar
  69. Hamlyn, A.N.; Lesna, M.; Record, C.O.; Smith, P.A.; Watson, A.J.; Meredith, T.J.; Volans, G.N. and Crome, P.: Methionine and cysteamine in paracetamol (acetaminophen) overdose, prospective controlled trial of early therapy. Journal of International Medical Research 9: 226–231 (1981).PubMedGoogle Scholar
  70. Hartwig-Otto, H.: Pharmacokinetic considerations of common analgesics and antipyretics. American Journal of Medicine 75 (Suppl.): 30–37 (1983).PubMedGoogle Scholar
  71. Harvey, J.G. and Spooner, J.B.: Paracetamol poisoning. British Medical Journal 2: 832–833 (1978).PubMedGoogle Scholar
  72. Helliwell, M.; Vale, A. and Goulding, R.: Haemoperfusion in ‘late’ paracetamol poisoning. Human Toxicology 1: 25–30 (1981).PubMedGoogle Scholar
  73. Hillman, R.J. and Prescott, L.F.: Salicylate intoxication: Rapid drug removal with repeated oral charcoal. British Medical Journal 291: 1472 (1985).PubMedGoogle Scholar
  74. Ho, S.W.-E. and Beilin, L.J.: Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases. British Medical Journal 287: 876–877 (1983).PubMedGoogle Scholar
  75. Howrie, D.L.; Moriarty, R. and Breit, R.: Candy flavouring as a source of salicylate poisoning. Pediatrics 75: 869–871 (1985).PubMedGoogle Scholar
  76. Hughes, R.D.; Trewby, P. and Williams, R.: Cysteamine for paracetamol poisoning. Lancet 1: 536 (1976).PubMedGoogle Scholar
  77. James, O.; Lesna, M.; Roberts, S.H.; Pulman, L.; Douglas, A.P.; Smith, P.A. and Watson, A.J.: Liver damage after paracetamol overdose. Comparison of liver function tests, fasting serum bile-acids, and liver histology. Lancet 2: 579–581 (1975).PubMedGoogle Scholar
  78. Johnson, P.N. and Welch, D.W.: Methyl salicylate/aspirin (salicylate) equivalence: Who do you trust? Veterinary and Human Toxicology 26: 317–318 (1984).PubMedGoogle Scholar
  79. Jones, D.I.R.: Self-poisoning with drugs: The past 20 years in Sheffield. British Medical Journal 1: 28–29 (1977).PubMedGoogle Scholar
  80. Jones, G. and Thomas, P.: Treatment of acute paracetamol poisoning. British Medical Journal 2: 1224 (1977).PubMedGoogle Scholar
  81. Juul, J.: Acute poisoning with butazolidin. Acta Pediatrica Scandinavica 54: 503–507 (1965).Google Scholar
  82. Kaufman, F.L. and Dubanksy, A.S.: Darvon poisoning with delayed salicylism: a case report. Pediatrics 49: 610–611 (1972).PubMedGoogle Scholar
  83. Kleinman, J.G.; Breitenfield, R.V. and Roth, D.A.: Acute renal failure associated with acetaminophen ingestion: Report of a case and review of the literature. Clinical Nephrology 14: 201–205 (1980).PubMedGoogle Scholar
  84. Klein-Schwartz, W. and Oderda, G.M.: Adsorption of oral antidotes for acetaminophen poisoning (methionine and n-acetylcysteine) by activated charcoal. Clinical Toxicology 18: 283–290 (1981).PubMedGoogle Scholar
  85. Koppel, C.; Wagemann, A.; Tenczer, J. and Muth, H.: Tiaprofenic acid overdose. Arzneimittel-Forschung 34: 836–837 (1984).PubMedGoogle Scholar
  86. Kramer, M.: Chronic toxicity of pyrazolones: The problem of nitrosation. British Journal of Clinical Pharmacology 10: 313S–317S (1980).PubMedGoogle Scholar
  87. Labadarios, D.; Davis, M.; Portmann, B. and Williams, R.: Paracetamol-induced hepatic necrosis in the mouse — relationship between covalent binding, hepatic glutathione depletion and the protective effect of α-mercaptopropionylglycine. Biochemical Pharmacology 26: 31–35 (1977).PubMedGoogle Scholar
  88. Lauterberg, B.H. and Mitchell, J.R.: Toxic doses of acetaminophen suppress hepatic glutathione synthesis in rats. Hepatology 2: 8–12 (1982).Google Scholar
  89. Lawson, A.A.H.; Proudfoot, A.T.; Brown, S.S.; Macdonald, H.; Fraser, A.G.; Cameron, J.C. and Matthew, H.: Forced diuresis in the treatment of acute salicylate poisoning in adults. Quarterly Journal of Medicine 38: 31–48 (1969).PubMedGoogle Scholar
  90. Leaf, G. and Neuberger, A.: The effect of diet on the glutathione content of the liver. Biochemical Journal 41: 280–287 (1947).Google Scholar
  91. Lee, C.S.; Wang, L.H.; Marbury, T.C. and Cade, J.R.: Hemodialysis for acetaminophen detoxification. Clinical Toxicology 18: 431–439 (1981).PubMedGoogle Scholar
  92. Levy, G.: Clinical pharmacokinetics of aspirin. Pediatrics 62 (Suppl.): 867–872 (1978).PubMedGoogle Scholar
  93. Levy, G. and Houston, J.B.: Effect of activated charcoal on acetaminophen absorption. Pediatrics 58: 432–435 (1976).PubMedGoogle Scholar
  94. Levy, G.; Khanna, N.N.; Soda, D.M.; Tsuzuki, O. and Stern, L.: Pharmacokinetics of acetaminophen in the human neonate: Formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics 55: 818–825 (1975).PubMedGoogle Scholar
  95. Lien-Lai, M.W.; Sarnaik, A.P.; Newton, J.F.; Miceli, J.N.; Fleischmann, L.E.; Hook, J.B. and Kauffman, R.E.: Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. Journal of Pediatrics 105: 125–128 (1984).Google Scholar
  96. Lo, G.O.C. and Chan, J.Y.W.: Piroxicam poisoning. British Medical Journal 287: 798 (1983).PubMedGoogle Scholar
  97. Lynd, P.A.; Andreasen, A.C. and Wyatt, R.J.: Intrauterine salicylate intoxication in a newborn. Clinical Pediatrics 15: 912–913 (1976).PubMedGoogle Scholar
  98. Macdougall, L.G.: Taylor-Smith, A.; Rothberg, A.D. and Thomson, P.D.: Piroxicam poisoning in a 2-year-old child. South African Medical Journal 61: 31–34 (1984).Google Scholar
  99. Maclean, D.; Peters, T.J.; Brown, R.A.G.; McCathie, M.; Baines, G.F. and Robertson, P.G.C.: Treatment of acute paracetamol poisoning. Lancet 2: 849–852 (1968).PubMedGoogle Scholar
  100. Makela, A.-L.; Lang, H. and Korpela, P.: Toxic encephalopathy with hyperammonaemia during high-dose salicylate therapy. Acta Neurologica Scandinavica 61: 146–151 (1980).PubMedGoogle Scholar
  101. Mant, T.G.K.; Tempowski, J.H.; Volans, G.N. and Talbot, J.C.C.: Adverse reactions to acetylcysteine and effects of overdose. British Medical Journal 289: 217–219, (1984).PubMedGoogle Scholar
  102. Matthew, H.; Mackintosh, T.F.; Tompsett, S.L. and Cameron, J.C.: Gastric aspiration and lavage in acute poisoning. British Medical Journal 1: 1333–1337 (1966).PubMedGoogle Scholar
  103. McCraken, J.S.: Salicylate intoxication in the elderly due to benorylate. British Medical Journal 288: 1694 (1984).Google Scholar
  104. McLean, A.E.M. and Day, P.A.: The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures. Biochemical Pharmacology 24: 37–42 (1975).PubMedGoogle Scholar
  105. Meredith, T.J.: Epidemiology of paracetamol poisoning. Report from 3rd Joint Meeting of the World Health Organisation, Regional Office for Europe and European Association of Poisons Control Centres, Copenhagen, May 20–22, pp 46–50 (1981).Google Scholar
  106. Meredith, T.J. and Goulding, R.: Paracetamol. Postgraduate Medical Journal 56: 459–473 (1980).PubMedGoogle Scholar
  107. Meredith, T.J. and Vale, J.A.: Salicylate poisoning; in Vale and Meredith (Eds.) Poisoning: Diagnosis and Treatment, pp. 97–103, (Update Books, London 1981).Google Scholar
  108. Meredith, T.J. and Vale, J.A.: Epidemiology of analgesic overdose in England and Wales. Human Toxicology 3: 61S–74S (1984).PubMedGoogle Scholar
  109. Meredith, T.J.; Crome, P.; Volans, G. and Goulding, R.: Treatment of paracetamol poisoning. British Medical Journal 1: 1215–1216 (1978a).PubMedGoogle Scholar
  110. Meredith, T.J.; Newman, B. and Goulding, R.: Paracetamol poisoning in children. British Medical Journal 2: 478–479 (1978b).PubMedGoogle Scholar
  111. Meredith, T.J.; Vale, J.A. and Goulding, R.: The epidemiology of acute acetaminophen poisoning in England and Wales. Archives of Internal Medicine 141: 397–400 (1981).PubMedGoogle Scholar
  112. Miller, R.P.; Roberts, R.J. and Fischer, L.J.: Acetaminophen elimination kinetics in neonates, children, and adults. Clinical Pharmacology and Therapeutics 19: 284–294 (1976).PubMedGoogle Scholar
  113. Mitchell, J.R.; Schenker, S.; Avant, G.R. and Speeg, K.V.: Cimetidine protects against acetaminophen hepatotoxicity in rats. Gastroenterology 81: 1052–1060 (1981).PubMedGoogle Scholar
  114. Mohandas, J.; Duggin, G.G.; Horvath, J.S. and Tiller, D.J.: Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney. Toxicology and Applied Pharmacology 61: 252–259 (1981).PubMedGoogle Scholar
  115. Moldeus, P.; Andersson, B.; Norling, A. and Ormstad, K.: Effect of chronic ethanol administration on drug metabolism in isolated hepatocytes with emphasis on paracetamol activation. Biochemical Pharmacology 29: 1741–1745 (1980).PubMedGoogle Scholar
  116. Mongan, E.; Kelly, P.; Nies, K.; Porter, W.W. and Paulus, H.E.: Tinnitus as an indication of therapeutic serum salicylate levels. Journal of the American Medical Association 226: 142–145 (1973).PubMedGoogle Scholar
  117. Mortimer, E.A. and Lepow, M.L.: Varicella with hypoglycemia possibly due to salicylates. American Journal of Diseases of Children 103: 583–590 (1962).PubMedGoogle Scholar
  118. Mosvold, J.; Mellem, H.; Stave, R.; Osnes, M. and Laufen, H.: Overdosage of piroxicam. Acta Medica Scandinavica 216: 335–336 (1984).PubMedGoogle Scholar
  119. Myers, E.N.; Bernstein, J.M. and Fostiropolous, G.: Salicylate ototoxicity: A clinical study. New England Journal of Medicine 273: 587–590 (1965).PubMedGoogle Scholar
  120. National Poisons Information Service Monitoring Group: Analgesic poisoning: A multicentre, prospective study. Human Toxicology 1: 7–23 (1981).Google Scholar
  121. Netter, P.; Lambert, H.; Larcan, A.; Godbillon, J. and Gosset, G.: Diclofenac sodium-chlormezanone poisoning. European Journal of Clinical Pharmacology 26: 535–536 (1984)PubMedGoogle Scholar
  122. Neuvonen, P.J. and Elonen, E.: Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. European Journal of Clinical Pharmacology 17: 51–57 (1980).PubMedGoogle Scholar
  123. Newman, T.J. and Bargman, G.J.: Acetaminophen hepatotoxicity and malnutrition. American Journal of Gastroenterology 72: 647–650 (1979).PubMedGoogle Scholar
  124. Nogen, A.G. and Bremner, J.E.: Fatal acetaminophen overdosage in a young child. Journal of Pediatrics 92: 832–833 (1978).PubMedGoogle Scholar
  125. North, D.S.; Peterson, R.G. and Krenzelok, E.P.: Effect of activated charcoal administration on acetylcysteine serum levels in humans. American Journal of Hospital Pharmacy 38: 1022–1024 (1981).PubMedGoogle Scholar
  126. Nusynowitz, M.L. and Forsham, P.H.: The antidiuretic action of acetaminophen. American Journal of the Medical Sciences 252: 429–435 (1966).PubMedGoogle Scholar
  127. Oie, S.; Lowenthal, D.T.; Briggs, W.A. and Levy, G.: Effect of hemodialysis on kinetics of acetaminophen elimination by anephric patients. Clinical Pharmacology and Therapeutics 18: 680–686 (1976).Google Scholar
  128. Okonek, S.: Intoxication with pyrazolones. British Journal of Clinical Pharmacology 10: 385S–390S (1980).PubMedGoogle Scholar
  129. Olkkola, K.T. and Neuvonen, P.J.: Do gastric contents modify antidotal efficacy of oral activated charcoal? British Journal of Clinical Pharmacology 18: 663–669 (1984).PubMedGoogle Scholar
  130. Paulozzi, L.J.: Seasonality of reported poison exposures. Pediatrics 71: 891–893 (1983).PubMedGoogle Scholar
  131. Paynter, A.S. and Alexander, F.W.: Salicylate intoxication caused by teething ointment. Lancet 2: 1132 (1979).PubMedGoogle Scholar
  132. Pessayre, D.; Dolder, A.; Artigou, J.-Y.; Wandscheer, J.-C.; Descatoire, V.; Degott, C. and Benhamou, J.-P.: Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 77: 264–271 (1979).PubMedGoogle Scholar
  133. Pessayre, D.; Wanscheer, J.-C.; Cobert, B.; Level, R.; Degott, C.; Batt, A.M.; Martin, N. and Benhamou, J.P.: Additive effects of inducers and fasting on acetaminophen hepatotoxicity. Biochemical Pharmacology 29: 2219–2223 (1980).PubMedGoogle Scholar
  134. Peterson, F.J.; Holloway, D.E.; Erickson, R.R.; Duquette, P.H.; McClain, C.J. and Holtzman, J.L.: Ethanol induction of acetaminophen toxicity and metabolism. Life Sciences 27: 1705–1711 (1980).PubMedGoogle Scholar
  135. Peterson, G.R.; Hostetler, R.M.; Lehman, T. and Covault, H.P.: Acute inhibition of oxidative drug metabolism by propoxyphene (Darvon). Biochemical Pharmacology 28: 1783–1789 (1979).PubMedGoogle Scholar
  136. Peterson, R.G. and Rumack, B.H.: Treating acute acetaminophen poisoning with acetylcysteine. Journal of the American Medical Association 237: 2406–2407 (1977).PubMedGoogle Scholar
  137. Peterson, R.G. and Rumack, B.H.: Age as a variable in acetaminophen overdose. Archives of Internal Medicine 141: 390–393 (1981).PubMedGoogle Scholar
  138. Pimstone, B.L. and Uys, C.J.: Liver necrosis and myocardiopathy following paracetamol overdosage. South African Medical Journal 42: 259–262 (1968).PubMedGoogle Scholar
  139. Portmann, B.; Talbot, I.C.; Day, D.W.; Davidson, A.R.; Murray-Lyon, I.M. and Williams, R.: Histopathological changes in the liver following a paracetamol overdose: Correlation with clinical and biochemical parameters. Journal of Pathology 117: 169–181 (1975).PubMedGoogle Scholar
  140. Prescott, L.F.: Haemodialysis in paracetamol self-poisoning. Lancet 1: 652 (1972).Google Scholar
  141. Prescott, L.F.: The nephrotoxicity and hepatotoxicity of antipyretic analgesics. British Journal of Clinical Pharmacology 7: 453–462 (1979).PubMedGoogle Scholar
  142. Prescott, L.F.: Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs 25: 290–314 (1983).PubMedGoogle Scholar
  143. Prescott, L.F.: Drug conjugation in clinical toxicology. Biochemical Society Transactions 12: 96–99 (1984).PubMedGoogle Scholar
  144. Prescott, L.F. and Critchley, J.A.J.H.: Drug interactions affecting analgesic toxicity. American Journal of Medicine 75 (Suppl.): 113–116 (1983)PubMedGoogle Scholar
  145. Prescott, L.F. and Wright, N.: The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study. British Journal of Pharmacology 49: 602–613 (1973).PubMedGoogle Scholar
  146. Prescott, L.F.; Wright, N.; Roscoe, P. and Brown, S.S.: Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1: 519–522 (1971).PubMedGoogle Scholar
  147. Prescott, L.F.; Newton, R.W.; Swainson, C.P.; Wright, N.; Forrest, A.R.W. and Matthew, H.: Successful treatment of severe paracetamol overdosage with cysteamine. Lancet 1: 588–592 (1974).PubMedGoogle Scholar
  148. Prescott, L.F.; Park, J.; Sutherland, G.R.; Smith, I.J. and Proudfoot, A.T.: Cysteamine, methionine and penicillamine in the treatment of paracetamol poisoning. Lancet 2: 109–113 (1976a).PubMedGoogle Scholar
  149. Prescott, L.F.; Park, J. and Proudfoot, A.T.: Cysteamine for paracetamol poisoning. Lancet 1: 357 (1976b).PubMedGoogle Scholar
  150. Prescott, L.F.; Park, J.; Ballantyne, A.; Adriaenssens, P. and Proudfoot, A.T.: Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 2: 432–434 (1977).PubMedGoogle Scholar
  151. Prescott, L.F.; Oswald, I. and Proudfoot, A.T.: Repeated self-poisoning with paracetamol. British Medical Journal 2: 1399 (1978a).PubMedGoogle Scholar
  152. Prescott, L.F.; Stewart, M.J. and Proudfoot, A.T.: Cysteamine or N-acetylcysteine for paracetamol poisoning? British Medical Journal 1: 856 (1978b).PubMedGoogle Scholar
  153. Prescott, L.F.; Illingworth, R.N.; Critchley, J.A.J.H.; Stewart, M.J.; Adam, R.D. and Proudfoot, A.T.: Intravenous N-acetylcysteine: The treatment of choice for paracetamol poisoning. British Medical Journal 2: 1097–1100 (1979).PubMedGoogle Scholar
  154. Prescott, L.F.; Critchley, J.A.J.H. and Balali-Mood, M.: Phenbylbutazone overdosage: Abdominal metabolism associated with hepatic and renal damage. British Medical Journal 281: 1106–1107 (1980).PubMedGoogle Scholar
  155. Prescott, L.F.; Critchley, J.A.J.H.; Balali-Mood, M. and Pentland, B.: Effects of microsomal enzyme induction on paracetamol metabolism in man. British Journal of Clinical Pharmacology 12: 149–153 (1981).PubMedGoogle Scholar
  156. Prescott, L.F.; Balali-Mood, M; Critchley, J.A.J.H.; Johnstone, A.F. and Proudfoot, A.T.: Diuresis or urinary alkalinisation for salicylate poisoning. British Medical Journal 285: 1383–1386 (1982a).PubMedGoogle Scholar
  157. Prescott, L.F.; Proudfoot, A.T. and Cregeen, R.J.: Paracetamol-induced acute renal failure in the absence of fulminant liver damage. British Medical Journal 284: 421–422 (1982b).PubMedGoogle Scholar
  158. Price, V.F. and Jollow, D.J.: Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. Journal of Pharmacology and Experimental Therapeutics 220: 504–513 (1982).PubMedGoogle Scholar
  159. Proudfoot, A.T.: Toxicity of salicylates. American Journal of Medicine 75 (Suppl.): 99–103 (1983).PubMedGoogle Scholar
  160. Proudfoot, A.T. and Brown, S.S.: Acidaemia and salicylate poisoning in adults. British Medical Journal 2: 547–550 (1969).PubMedGoogle Scholar
  161. Proudfoot, A.T. and Wright, N.: Acute paracetamol poisoning. British Medical Journal 3: 557–558 (1970).PubMedGoogle Scholar
  162. Queneau, P.; Barthelemy, C. and Fulchiron, P.: Ingestion massive d’indometacine en prise unique (A propos de 2 observations personnelles). Lyon Médical 239: 133–136 (1978).Google Scholar
  163. Record, C.O.; Chase, R.A.; Alberti, K.G.M.M. and Williams, R.: Disturbances in glucose metabolism in patients with liver damage due to paracetamol overdose. Clinical Science and Molecular Medicine 49: 473–479 (1975).PubMedGoogle Scholar
  164. Roberts I.; Robinson, M.J.; Mughal, M.Z.; Ratcliffe, J.G. and Prescott, L.F.: Paracetamol metabolites in the neonate following maternal overdose. British Journal of Clinical Pharmacology 18: 201–206 (1984).PubMedGoogle Scholar
  165. Roberts, S.M. and Franklin, M.R.: Modification of hepatic microsomal oxidative drug metabolism in rats by the opiate maintenance drugs acetylmethadol, propoxyphene and methadone. Life Sciences 25: 845–852 (1979).PubMedGoogle Scholar
  166. Robins, J.B.; Turnbull, J.A. and Robertson, C.: Gastric perforation after acute aspirin overdose. Human Toxicology 4: 527–528 (1985).PubMedGoogle Scholar
  167. Rose, P.G.: Paracetamol overdose and liver damage. British Medical Journal 1: 381–382 (1969).PubMedGoogle Scholar
  168. Rumack, B.H.: Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases. American Journal of Diseases of Children 138: 428–433 (1984).PubMedGoogle Scholar
  169. Rumack, B.H.; Peterson, R.C.; Koch, G.G. and Amara, I.A.: Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Archives of Internal Medicine 141: 380–385 (1981).PubMedGoogle Scholar
  170. Sanerkin, N.G.: Acute myocardial necrosis in paracetamol poisoning. British Medical Journal 3: 478 (1971).PubMedGoogle Scholar
  171. Scherz, R.G.: Safety packaging impact on childhood poisonings in the United States. Veterinary and Human Toxicology 21 (Suppl.): 127–131 (1979).PubMedGoogle Scholar
  172. Shi, E.C.P.; Fisher, R.; McEvoy, M.; Ventol, R.; Rose, M. and Ham, J.M.: Factors influencing hepatic glutathione concentrations: A study in surgical patients. Clinical Science 62: 279–283 (1982).PubMedGoogle Scholar
  173. Shipton, E.A. and Müller, F.O.: Severe mefenamic acid poisoning. A case report. South African Medical Journal 67: 823–824 (1985).PubMedGoogle Scholar
  174. Sibert, J.R.; Craft, A.W. and Jackson, R.H.: Child-resistant packaging and accidental child poisoning. Lancet 2: 289–290 (1977).PubMedGoogle Scholar
  175. Siegers, C.P.; Strubelt, O. and Schutt, A.: Relations between hepatotoxicity and pharmacokinetics of paracetamol in rats and mice. Pharmacology 16: 273–278 (1978).PubMedGoogle Scholar
  176. Slattery, J.T. and Levy, G.: Acetaminophen kinetics in acutely poisoned patients. Clinical Pharmacology and Therapeutics 25: 184–195 (1979).PubMedGoogle Scholar
  177. Smith, J.M.; Roberts, W.O.; Hall, S.M.; White, T.A. and Gilbertson, A.A.: Late treatment of paracetamol poisoning with mercaptamine. British Medical Journal 1: 331–333 (1978).PubMedGoogle Scholar
  178. Spooner J.B. and Cleaver G.J.: Hepatotoxic dose of paracetamol. Letter to Editor. Lancet 2: 89 (1977).PubMedGoogle Scholar
  179. Stachura, I.; Jayakumar, S. and Bourke, E.: T and B lymphocyte subsets in fenoprofen nephropathy. American Journal of Medicine 75: 9–16 (1983).PubMedGoogle Scholar
  180. Stewart, M.J. and Simpson, E.: Prognosis in paracetamol self-poisoning: The use of plasma paracetamol concentration in a region without a poisoning treatment centre. Annals of Clinical Biochemistry 10: 173–178 (1973).Google Scholar
  181. Streeter, A.J. and Timbrell, J.A.: The effect of dichloralphenazone pretreatment on paracetamol hepatotoxicity in mice. Biochemical Pharmacology 28: 3035–3037 (1979).PubMedGoogle Scholar
  182. Strong, J.E.; Wilson, J.; Douglas, J.F. and Coppel, D.L.: Phenylbutazone self-poisoning treated by charcoal haemoperfusion. Anaesthesia 34: 1038–1040 (1979).PubMedGoogle Scholar
  183. Strubelt, O.: Interactions between ethanol and other hepatotoxic agents. Biochemical Pharmacology 29: 1445–1449 (1980).PubMedGoogle Scholar
  184. Strubelt, O.; Siegers, C.P. and Schutt, A.: The curative effects of cysteamine, cysteine and dithiocarb in experimental paracetamol poisoning. Archives of Toxicology 33: 55–64 (1974).PubMedGoogle Scholar
  185. Strubelt, O.; Obermeier, F. and Siegers, C.P.: The influence of ethanol pretreatment in the effects of nine hepatotoxic agents. Acta Pharmacologica et Toxicologica 43: 211–218 (1978).PubMedGoogle Scholar
  186. Symon, D.N.K. and Russell, G.: Fatal benorylate poisoning in a child with cystic fibrosis. Lancet 1: 77 (1983).PubMedGoogle Scholar
  187. Symon, D.N.K.; Gray, E.S.; Hanmer, O.J. and Russell, G.: Fatal paracetamol poisoning from benorylate therapy in a child with cystic fibrosis. Lancet 2: 1153–1154 (1982).PubMedGoogle Scholar
  188. Temple, A.R.: Pathophysiology of aspirin overdosage toxicity, with implications for management. Pediatrics 62 (Suppl.): 873–876 (1978).PubMedGoogle Scholar
  189. Temple, A.R.; George, D.J.; Done, A.K. and Thompson, J.A.: Salicylate poisoning complicated by fluid retention. Clinical Toxicology 9: 61–68 (1976).PubMedGoogle Scholar
  190. Tenenbein, M.: Hypersensitivity-like reactions to N-acetylcysteine. Veterinary and Human Toxicology 26(Suppl. 2): 3–5 (1984).PubMedGoogle Scholar
  191. Teschke, R.; Stutz, G. and Strohmeyer, G.: Increased paracetamol-induced hepatotoxicity after chronic alcohol consumption. Biochemical and Biophysical Research Communications 91: 368–374 (1979).PubMedGoogle Scholar
  192. Thomson, J.S. and Prescott, L.F.: Liver damage and impaired glucose tolerance after paracetamol overdosage. British Medical Journal 2: 506–507 (1966).PubMedGoogle Scholar
  193. Thurston, J.H.; Pollock, P.G.; Warren, S.K. and Jones, E.M.: Reduced brain glucose with normal plasma glucose in salicylate poisoning. Journal of Clinical Investigation 49: 2139–2145 (1970).PubMedGoogle Scholar
  194. Toghill, P.J.; Williams, R.; Stephens, J.D. and Carroll, J.D.: Acute hepatic necrosis following an overdose of paracetamol. Gastro-enterology 56: 773–776 (1969).Google Scholar
  195. Upadhyay, H.P. and Gupta, S.K.: Diflunisal (Dolobid) overdose. British Medical Journal 2: 640 (1978).PubMedGoogle Scholar
  196. Vale, J.A. and Buckley, B.M.: Asthma associated with N-acetylcysteine infusion and paracetamol poisoning. British Medical Journal 287: 1223 (1983).PubMedGoogle Scholar
  197. Vale, J.A. and Meredith, T.J.: Metabolic acidosis in paracetamol poisoning. British Medical Journal 285: 1208 (1982).Google Scholar
  198. Vale, J.A. and Meredith, T.J.: Acute poisoning with non-steroidal anti-inflammatory drugs: Clinical features and management. Medical Toxicology 1: 12–31 (1986).PubMedGoogle Scholar
  199. Vale, J.A. and Wheeler, D.C.; Anaphylactoid reactions to acetylcysteine. Lancet 2: 988 (1982).PubMedGoogle Scholar
  200. Vale, J.A.; Meredith, T.J.; Crome, P.; Helliwell, M.; Volans, G.N.; Widdop, B. and Goulding, R.: Intravenous N-acetylcysteine: The treatment of choice in paracetamol poisoning? British Medical Journal 2: 1435–1436 (1979).PubMedGoogle Scholar
  201. Vale, J.A.; Meredith, T.J. and Goulding, R.: Treatment of acetaminophen poisoning. The use of oral methionine. Archives of Internal Medicine 141: 394–396 (1981).PubMedGoogle Scholar
  202. Vale, J.A.; Buckley, B.M. and Meredith, T.J.: Deaths from paracetamol and dextropropoxyphene (Distalgesic) poisoning in England and Wales in 1979. Human Toxicology 3: 135S–143S (1984).PubMedGoogle Scholar
  203. Walker, B.E.; Kelleher, J.; Dixon, M.F. and Losowsky, M.S.: Vitamin E protection of the liver from paracetamol in the rat. Clinical Science and Molecular Medicine 47: 449–459 (1974).PubMedGoogle Scholar
  204. Walker, R.M.; McElligott, T.E.; Power, E.M.; Massey, T.E. and Racz, W.J.: Increased acetaminophen-induced hepatotoxicity after chronic ethanol consumption in mice. Toxicology 28: 193–206 (1983).PubMedGoogle Scholar
  205. Waltner, J.G.: The effect of salicylates on the inner ear. Annals of Otology, Rhinology and Laryngology 64: 617–622 (1955).Google Scholar
  206. Walton, N.G.; Mann, T.A.N. and Shaw, K.M.: Anaphylactoid reaction to N-acetylcysteine. Lancet 2: 1298 (1979).PubMedGoogle Scholar
  207. Waugh, P.K. and Keatinge, D.W.: Hypoprothrombinaemia in naproxen overdose. Drug Intelligence and Clinical Pharmacy 17: 549–550 (1983).PubMedGoogle Scholar
  208. Weiser, J.R.; Botzler, R.; Pentz, R. and Siegers, C.-P.: Klinik und verlauf einer Vergiftung mit piroxicam. Deutsche Medizinische Wochenschrift 109: 1583 (1984).PubMedGoogle Scholar
  209. Wendel, A.; Feuerstein, S. and Konz, K.-H.: Acute paracetamol intoxication of starved mice leads to lipid peroxidation in vivo. Biochemical Pharmacology 28: 2051–2055 (1979).PubMedGoogle Scholar
  210. Weston, M.T.; Talbot, I.C.; Howorth, P.J.N.; Mant, A.K.; Capildeo, R. and Williams, R.: Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. British Heart Journal 38: 1179–1188 (1976).PubMedGoogle Scholar
  211. Wilkinson, S.P.; Moodie, H.; Arroyo, V.A. and Williams, R.: Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. Journal of Clinical Pathology 30: 141–143 (1977).PubMedGoogle Scholar
  212. Wilson, J.T.; Kasantikul, V.; Harbison, R. and Martin, D.: Death in an adolescent following an overdose of aetaminophen and phenobarbital. American Journal of Diseases of Children 132: 466–473 (1978).PubMedGoogle Scholar
  213. Winchester, J.F.; Gelfand, M.C.; Knepshield, J.H. and Schreiner, G.E.: Dialysis and hemoperfusion of poisons and drugs — update. Transactions of the American Society of Artificial and Internal Organs 23: 762–842 (1977).Google Scholar
  214. Winters, R.W.; White, J.S.; Hughes, M.D. and Ordway, M.C.: Disturbance of acid-base equilibrium in salicylate intoxication. Pediatrics 23: 260–285 (1959).PubMedGoogle Scholar
  215. Wolhoff, H.; Altrogge, G.; Pola, W.; Sistovaris, N.: Metamizole — a case of acute overdosage with suicidal intent. Deutsche Medizinische Wochenschrift 108: 1761–1764 (1983).PubMedGoogle Scholar
  216. Wrammer, T.: A case of poisoning with 10 grams of butazolidin. Acta Rheumatologica Scandinavica 3: 83–91 (1957).Google Scholar
  217. Wright, N. and Prescott, L.F.: Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. Scottish Medical Journal 18: 56–58 (1973).Google Scholar
  218. Young, R.J.: Mefenamic acid poisoning and epilepsy. British Medical Journal 2: 672 (1979).PubMedGoogle Scholar
  219. Zezulka, A. and Wright, N.: Severe metabolic acidosis early in paracetamol poisoning. British Medical Journal 285: 851–852 (1982).PubMedGoogle Scholar
  220. Zimmerman, H.J.: Effects of aspirin and acetaminophen on the liver. Archives of Internal Medicine 141: 333–342 (1981).PubMedGoogle Scholar

Copyright information

© ADIS Press Limited 1986

Authors and Affiliations

  • T. J. Meredith
    • 1
  • J. A. Vale
    • 2
    • 3
  • Y. A. Vale
    • 2
  1. 1.Department of MedicineGuy’s HospitalLondonEngland
  2. 2.West Midlands Poisons UnitDudley Road HospitalBirminghamEngland
  3. 3.Department of Therapeutics and Clinical PharmacologyUniversity of BirminghamBirminghamEngland

Personalised recommendations